Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010
- PMID: 25387450
- PMCID: PMC9507265
- DOI: 10.1017/S0950268814002970
Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000-2010
Abstract
Literature surrounding the burden of and factors associated with hepatitis B virus (HBV) and hepatitis C virus (HCV) infection in persons with tuberculosis (TB) disease remains limited and focused on populations outside the USA. Cross-matched New York City (NYC) TB and viral hepatitis surveillance data were used to estimate the proportion of NYC adults diagnosed with TB from 2000 to 2010 with a report of viral hepatitis infection and to describe the impact of viral hepatitis infection on TB treatment completion and death. For 9512 TB patients, HCV infection was reported in 4.2% and HBV infection in 3.7%; <1% of TB patients had both HCV and HBV infection. The proportion of TB patients with HCV infection to die before TB treatment completion was larger than in TB patients without a viral hepatitis report (21% vs. 9%); this association remained when stratified by HIV status. There was no significant difference in death before treatment completion for TB patients with HBV infection compared to TB patients without a viral hepatitis report when stratified by HIV status. These findings reinforce the importance of hepatitis testing and providing additional support to TB patients with viral hepatitis infection.
Keywords: Hepatitis C; hepatitis B; infectious disease epidemiology; surveillance; tuberculosis (TB).
Conflict of interest statement
None.
Figures
References
-
- World Health Organization. Global tuberculosis report, 2013.
-
- Centers for Disease Control and Prevention. Reported Tuberculosis in the United States, 2012. October 2013 (http://apps.who.int/iris/bitstream/10665/91355/1/9789241564656_eng.pdf?ua=1). Accessed 2 May 2014.
-
- King L, Munsiff S, Ahuja S. Achieving international targets for tuberculosis treatment success among HIV-positive patients in New York City. International Journal of Tuberculosis and Lung Disease 2010; 14: 1613–1620. - PubMed
-
- Marais BJ, et al. Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts. Lancet Infectious Diseases 2013; 13: 436–448. - PubMed
-
- Alisjahbana B, et al. The effect of type 2 diabetes mellitus on the presentation and treatment response of pulmonary tuberculosis. Clinical Infectous Diseases 2007; 45: 428–435. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical